CNO · CNO Financial Group, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Average yield on allocated investments | 4.91% | 2Q26 | — |
| Book value per diluted share, excluding accumulated other comprehensive income (loss) non-GAAP | $39.92 | 2Q26 | — |
| Client Assets in Brokerage and Advisory | 5.69B | 2Q26 | — |
| consolidated statutory risk-based capital ratio non-GAAP | 377% | 2Q26 | — |
| Debt to Capital non-GAAP | 26.1% | 2Q26 | — |
| Earned yield | 4.88% | 2Q26 | — |
| Expense Ratio non-GAAP | 18.4% | 2Q26 | — |
| Free Cash Flow non-GAAP | 30.7M | 2Q26 | — |
| Insurance Product Margin Excluding Significant Items non-GAAP | 279M | 2Q26 | — |
| Net New Client Assets in Brokerage and Advisory | 195.7M | 2Q26 | — |
| Net operating income non-GAAP | $119.5M | 2Q26 | — |
|
|
|||
| New money rate | 6.16% | 2Q26 | — |
| Registered Agent Counts | 792 | 2Q26 | — |
| Rolling Twelve Months Expense Ratio non-GAAP | 18.5% | 2Q26 | — |
| Total Net Investment Income non-GAAP | 327.5M | 2Q26 | — |
| TTM operating ROE non-GAAP | 14.1% | 2Q26 | — |
| Value of NOLs | 189M | as of June 30, 2026 | — |
| Consumer producing agent count growth streak | 13 | Q1 2026 | — |
| Operating earnings per share non-GAAP | $1.05 | Q1 2026 | — |
| Total Medicare policies sold | 24% | Q1 2026 | — |
| Worksite producing agent count growth streak | 15 | Q1 2026 | — |
| Net operating income, excluding significant items non-GAAP | $401.7M | Full year 2025 | — |
GAAP → non-GAAP reconciliationGAAP Net operating income $439.2M
-$37.5M Significant items
= Net operating income, excluding significant items $401.7M
|
|||
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Insurance - Life — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CNO
this stock
CNO Financial Group, Inc.
|
$4.95B | +25.5% | +0.9% | 18.4 | 1.7% |
|
CILJF
China Life Insurance Co Ltd
|
$97.80B | +0.4% | — | — | 0.0% |
|
MFC
Manulife Financial Corp
|
$73.51B | +19.7% | — | — | 0.8% |
|
MET
Metlife Inc
|
$61.44B | +20.5% | +8.6% | 18.5 | 1.8% |
|
AFL
Aflac Inc
|
$61.03B | +5.7% | -9.3% | 13.1 | 2.5% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CNO | -1.8% | +0.4% | +23.8% | -3.3% | +25.5% |
| SPY | -0.4% | +2.9% | +11.6% | +3.0% | +12.8% |
| vs SPY | -1.4% | -2.5% | +12.2% | -6.2% | +12.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.